Search results
Results From The WOW.Com Content Network
Since at least the 1990s, scientists have researched whether the now-ubiquitous radiation associated with mobile phone antennas or cell phone towers is affecting human health. [1] Mobile phone networks use various bands of RF radiation, some of which overlap with the microwave range. Other digital wireless systems, such as data communication ...
Mayo v. Prometheus, 566 U.S. 66 (2012), was a case decided by the Supreme Court of the United States that unanimously held that claims directed to a method of giving a drug to a patient, measuring metabolites of that drug, and with a known threshold for efficacy in mind, deciding whether to increase or decrease the dosage of the drug, were not patent-eligible subject matter.
Methadone. Methadone, sold under the brand names Dolophine and Methadose among others, is a synthetic opioid agonist used for chronic pain and also for opioid use disorder. [ 7] It is used to treat chronic pain, and it is also used to treat addiction to heroin or other opioids. [ 10][ 11] Prescribed for daily use, the medicine relieves cravings ...
Pharmacology. An adverse effect is an undesired harmful effect resulting from a medication or other intervention, such as surgery. [ 1] An adverse effect may be termed a "side effect", when judged to be secondary to a main or therapeutic effect. The term complication is similar to adverse effect, but the latter is typically used in ...
Lisdexamfetamine is a substituted amphetamine with an amide linkage formed by the condensation of dextroamphetamine with the carboxylate group of the essential amino acid L -lysine. [ 22] The reaction occurs with retention of stereochemistry, so the product lisdexamfetamine exists as a single stereoisomer.
Duloxetine, sold under the brand name Cymbalta among others, [ 1] is a medication used to treat major depressive disorder, generalized anxiety disorder, obsessive-compulsive disorder, fibromyalgia, neuropathic pain and central sensitization. [ 7][ 8] It is taken by mouth. [ 7]
The maker of Robitussin settled a consumer lawsuit that claimed its "non-drowsy" cough and flu medicine causes drowsiness, agreeing to pay $4.5 million and remove the "non-drowsy" claim from its ...
These side effects may occur in as many as 90% of men treated with bicalutamide monotherapy, [29] but gynecomastia is generally reported to occur in 70 to 80% of patients. [30] In the EPC trial, at a median follow-up of 7.4 years, breast pain and gynecomastia respectively occurred in 73.6% and 68.8% of men treated with 150 mg/day bicalutamide ...